ARCHIVES

In Brief: Phil Amoruso Will Be The New NCI Executive Officer; DRCCA Board Okays CCN Extension

This article is from The Cancer Letter archive.

Vol. 07 No. 01 | January 2, 1981

Download PDF Visit The Full Archive

Related Articles

ImClone Protocol Generates More Questions Than Answers

March 8, 2002

ACS Defends Dialogue, Calls Story “Misleading”.

October 20, 2000

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

Final Regulations For Clinical Cancer Education Program Adopted

October 3, 1975

FDA News: Rep. Barton Expresses “Concern” About Plan To Merge Offices

May 22, 1998

Coalitions Urges Members To Call, Write, Congress

May 3, 1991